tirzepatide maximum weight loss surmount trials for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Trial profile SURMOUNT-3 CONSORT flow

Semaglutide can interact with certain drugs, particularly those that also affect blood sugar, like insulin or sulfonylureas

Experts said the study was promising but that more research is needed before doctors prescribe the drugs to people who are not overweight

Americans have been increasingly pushed to the cash-pay market for the medications

Oral semaglutide is indicated for use as an add-on combination therapy (with other glucose-lowering agents, including insulin) or as a monotherapy (in patients who are intolerant to metformin) for type 2 diabetes when diet and exercise do not provide adequate glycemic control